PFIZER INC Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31)
PFIZER INC (PFE) reported Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) of $506.00 million for the 3-month period ending 2012-04-01, per its 10-Q filed 2012-05-10.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease · last filed 2012-05-10
- PFIZER INC other comprehensive income (loss), net of tax (deprecated 2012-01-31) for the quarter ending 2012-04-01 was $506.00M, a 63.44% decline year-over-year.
- PFIZER INC other comprehensive income (loss), net of tax (deprecated 2012-01-31) for the quarter ending 2011-12-31 was -$2.96B, a 1217.74% decline year-over-year.
- PFIZER INC other comprehensive income (loss), net of tax (deprecated 2012-01-31) for the quarter ending 2011-10-02 was -$262.00M, a 137.01% decline year-over-year.
- PFIZER INC other comprehensive income (loss), net of tax (deprecated 2012-01-31) for the quarter ending 2011-07-03 was $1.11B.
- PFIZER INC other comprehensive income (loss), net of tax (deprecated 2012-01-31) for fiscal 2011 was -$734.00M.
- PFIZER INC other comprehensive income (loss), net of tax (deprecated 2012-01-31) for fiscal 2010 was -$3.99B, a 177.76% decline from fiscal 2009.
- PFIZER INC other comprehensive income (loss), net of tax (deprecated 2012-01-31) for fiscal 2009 was $5.13B.
- PFIZER INC other comprehensive income (loss), net of tax (deprecated 2012-01-31) for fiscal 2008 was -$6.83B, a 346.32% decline from fiscal 2007.
| Period end | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) 3 month | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) 3 month as first filed | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) 6 month | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) 9 month | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) 12 month | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|
| 2012-04-01 | $506.00M 10-Q · filed 2012-05-10 | -$2.46B derived: sum of 2 quarters · filed 2012-05-10 | -$2.72B derived: sum of 3 quarters · filed 2012-05-10 | -$1.61B derived: sum of 4 quarters · filed 2012-05-10 | ||
| 2011-12-31 | -$2.96B derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | -$3.22B derived: sum of 2 quarters · filed 2012-02-28 | -$2.12B derived: sum of 3 quarters · filed 2012-02-28 | -$734.00M 10-K · filed 2012-02-28 | ||
| 2011-10-02 | -$262.00M 10-Q · filed 2011-11-10 | $844.00M derived: sum of 2 quarters · filed 2011-11-10 | $2.23B 10-Q · filed 2011-11-10 | $2.49B derived: sum of 4 quarters · filed 2012-05-10 | ||
| 2011-07-03 | $1.11B 10-Q · filed 2011-08-11 | $2.49B 10-Q · filed 2011-08-11 | $2.75B derived: sum of 3 quarters · filed 2012-05-10 | $3.46B derived: sum of 4 quarters · filed 2012-05-10 | ||
| 2011-04-03 | $1.38B 10-Q · filed 2012-05-10 | $1.65B derived: sum of 2 quarters · filed 2012-05-10 | $2.36B derived: sum of 3 quarters · filed 2012-05-10 | -$90.00M derived: sum of 4 quarters · filed 2012-05-10 | ||
| 2010-12-31 | $265.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $973.00M derived: sum of 2 quarters · filed 2012-02-28 | -$1.47B derived: sum of 3 quarters · filed 2012-02-28 | -$3.99B 10-K · filed 2012-02-28 | -$3.99B 10-K · filed 2011-02-28 | |
| 2010-10-03 | $708.00M 10-Q · filed 2011-11-10 | -$1.74B derived: sum of 2 quarters · filed 2011-11-10 | -$4.25B 10-Q · filed 2011-11-10 | -$1.80B derived: sum of 4 quarters · filed 2012-02-28 | ||
| 2010-07-04 | -$2.45B 10-Q · filed 2011-08-11 | -$2.45B 10-Q · filed 2010-08-12 | -$4.96B 10-Q · filed 2011-08-11 | -$2.51B derived: sum of 3 quarters · filed 2012-02-28 | -$2.32B derived: sum of 4 quarters · filed 2012-02-28 | |
| 2010-04-04 | -$2.51B 10-Q · filed 2011-05-12 | -$59.00M derived: sum of 2 quarters · filed 2012-02-28 | $124.00M derived: sum of 3 quarters · filed 2012-02-28 | $2.72B derived: sum of 4 quarters · filed 2012-02-28 | ||
| 2009-12-31 | $2.45B derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $2.64B derived: sum of 2 quarters · filed 2012-02-28 | $5.23B derived: sum of 3 quarters · filed 2012-02-28 | $5.13B 10-K · filed 2012-02-28 | $5.13B 10-K · filed 2010-02-26 | |
| 2009-09-27 | $183.00M 10-Q · filed 2010-11-12 | $2.78B derived: sum of 2 quarters · filed 2010-11-12 | $2.67B 10-Q · filed 2010-11-12 | |||
| 2009-06-28 | $2.59B 10-Q · filed 2010-08-12 | $2.49B 10-Q · filed 2010-08-12 | ||||
| 2008-12-31 | -$6.83B 10-K · filed 2011-02-28 | |||||
| 2007-12-31 | $2.77B 10-K · filed 2010-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |